Works matching IS 03407004 AND DT 2018 AND VI 67 AND IP 5

Results: 15

Cancer immunotherapy in patients with brain metastases.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 703, doi. 10.1007/s00262-018-2146-8

By:

Caponnetto, Salvatore;
Draghi, Arianna;
Borch, Troels Holz;
Nuti, Marianna;
Cortesi, Enrico;
Svane, Inge Marie;
Donia, Marco

Publication type:

Article

Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 843, doi. 10.1007/s00262-018-2141-0

By:

Domouchtsidou, Aglaia;
Barsegian, Vahé;
Mueller, Stefan P.;
Best, Jan;
Ertle, Judith;
Bedreli, Sotiria;
Horn, Peter A.;
Bockisch, Andreas;
Lindemann, Monika

Publication type:

Article

PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 805, doi. 10.1007/s00262-018-2138-8

By:

Varki, Vinod;
Ioffe, Olga B.;
Bentzen, Soren M.;
Heath, Jon;
Cellini, Ashley;
Feliciano, Josephine;
Zandberg, Dan P.

Publication type:

Article

The Third Institute for Cancer Vaccines and Immunotherapy (ICVI) symposium on immunotherapy: May 12-13, 2017, Royal Society, London, UK.

Published in:

2018

By:

Dalgleish, Angus G

Publication type:

Proceeding

The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 815, doi. 10.1007/s00262-018-2136-x

By:

Läubli, Heinz;
Müller, Philipp;
D’Amico, Lucia;
Buchi, Mélanie;
Kashyap, Abhishek S.;
Zippelius, Alfred

Publication type:

Article

Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 835, doi. 10.1007/s00262-018-2135-y

By:

Koziol, James A.;
Imai, Haruhiko;
Dai, Liping;
Zhang, Jian-Ying;
Tan, Eng M.

Publication type:

Article

Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 825, doi. 10.1007/s00262-018-2134-z

By:

Kähler, Katharina C.;
Eigentler, Thomas K.;
Gesierich, Anja;
Heinzerling, Lucie;
Loquai, Carmen;
Meier, Friedegund;
Meiss, Frank;
Pföhler, Claudia;
Schlaak, Max;
Terheyden, Patrick;
Thoms, Kai M.;
Ziemer, Mirjana;
Zimmer, Lisa;
Gutzmer, Ralf;
For the German Dermatologic Cooperative Oncology Group (DeCOG)

Publication type:

Article

Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 785, doi. 10.1007/s00262-018-2133-0

By:

Kamensek, Urska;
Cemazar, Maja;
Lampreht Tratar, Ursa;
Ursic, Katja;
Sersa, Gregor

Publication type:

Article

TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 761, doi. 10.1007/s00262-018-2130-3

By:

Mukherjee, Sumit;
Hussaini, Rahman;
White, Richard;
Atwi, Doaa;
Fried, Angela;
Sampat, Samay;
Piao, Longzhu;
Pan, Quintin;
Banerjee, Probal

Publication type:

Article

The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 775, doi. 10.1007/s00262-018-2129-9

By:

Dörfel, Daniela;
Lechner, Christian J.;
Joas, Simone;
Funk, Tanja;
Gutknecht, Michael;
Salih, Julia;
Geiger, Julian;
Kropp, Korbinian N.;
Maurer, Stefanie;
Müller, Martin R.;
Kopp, Hans-Georg;
Salih, Helmut R.;
Grünebach, Frank;
Rittig, Susanne M.

Publication type:

Article

Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 739, doi. 10.1007/s00262-018-2128-x

By:

Ringelstein-Harlev, Shimrit;
Avivi, Irit;
Fanadka, Mona;
Horowitz, Netanel A.;
Katz, Tami

Publication type:

Article

Certain BCG-reactive responses are associated with bladder cancer prognosis.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 797, doi. 10.1007/s00262-018-2127-y

By:

Shan, Guang;
Tang, Tian;
Qian, Huijun;
Xia, Yue

Publication type:

Article

Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysis.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 713, doi. 10.1007/s00262-018-2126-z

By:

Jiang, Tao;
Qiao, Meng;
Zhao, Chao;
Li, Xuefei;
Gao, Guanghui;
Su, Chunxia;
Ren, Shengxiang;
Zhou, Caicun

Publication type:

Article

Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 749, doi. 10.1007/s00262-018-2124-1

By:

Gacerez, Albert T.;
Hua, Casey K.;
Ackerman, Margaret E.;
Sentman, Charles L.

Publication type:

Article

Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph node.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 729, doi. 10.1007/s00262-018-2123-2

By:

McDaniel, Jonathan R.;
Pero, Stephanie C.;
Voss, William N.;
Shukla, Girja S.;
Sun, Yujing;
Schaetzle, Sebastian;
Lee, Chang-Han;
Horton, Andrew P.;
Harlow, Seth;
Gollihar, Jimmy;
Ellefson, Jared W.;
Krag, Christopher C.;
Tanno, Yuri;
Sidiropoulos, Nikoletta;
Georgiou, George;
Ippolito, Gregory C.;
Krag, David N.

Publication type:

Article